Research Projects & Grants

  • Biologic for the Treatment of High Risk B Cell Acute Lymphoblastic Leukemia, Role: PI, (09/2022 - 09/2025) Status: Approved
  • Glucocorticoid signaling, taxane resistance, and prostate cancer health disparities, Role: Investigator, (04/2021 - 04/2024) Status: Approved

College/University

  • STEM CELL SCHOLARS - 2020, Role: PD/PI, California State University, San Bernardino, (01/2020 - 12/2020) Status: Closed
  • Stem Cell Scholars, Role: Principal Investigator, California State University, San Bernardino, (01/2018 - 12/2018) Status: Closed
  • CSUSB Bridges Stem Cell Research, Role: Principal Investigator, California State University, San Bernardino, (04/2017 - 09/2017) Status: Closed

Federal

  • LLU-NIH Initiative for Maximizing Student Development, Role: Other Significant Contributor, National Institute of General Medical Sciences/NIH/DHHS, (01/2018 - 12/2023) Status: Awarded

Internal

  • Ovarian cancer xenograft models, Role: PI, LLU School of Medicine, (03/2024 - 03/2027) Status: Approved
  • Alveolar bone regeneration via reprogrammed GMSCs (gingival mesenchymal stem cells) as a periodontal therapy, Role: Investigator, LLU Center for Dental Research, (06/2017 - 06/2018) Status: Completed
  • LLU Cancer Center biospecimen laboratory - specimens collection protocol, Role: Investigator, LLU Cancer Institute, (09/2023 - 09/2024) Status: Approved
  • Collection of female reproductive tissue samples, Role: PI, LLU Basic Science, (01/2015 - 01/2016) Status: Completed
  • The impact of bariatric surgery on periodontal health, Role: Co-Investigator, LLU - GRASP, (01/2024 - 12/2025) Status: Awarded
  • GCAT 2024 - Reversing Chemoresistance in Organoid and Patient-Derived Xenograft Models of Ovarian Cancer, Role: PD/PI, LLU School of Medicine, (01/2024 - 12/2025) Status: Awarded
  • Reversing Chemoresistance in Recurrent Ovarian Cancer, Role: PD/PI, LLU School of Medicine, (01/2022 - 12/2024) Status: Awarded
  • Cancer cell aggressiveness caused by conventional vs. proton radiation, Role: PD/PI, LLU School of Medicine, (01/2020 - 12/2023) Status: Closed
  • Improving genetic testing rates to enable targeted therapy: Novel combination therapy targeting Snail and PARP for advanced ovarian cancer in Hispanic women, Role: PD/PI, LLU School of Medicine, (01/2018 - 12/2021) Status: Closed
  • Alveolar Bone Regeneration via Reprogrammed Gingival Mesenchymal Stem Cell as a Periodontal Therapy, Role: PD/PI, LLU School of Dentistry, (02/2016 - 02/2018) Status: Closed
  • Development of a metastatic ovarian cancer patient-derived xenograft model, Role: PD/PI, LLU School of Medicine, (01/2015 - 12/2016) Status: Closed

Non-Profit Organization

  • Improving genetic testing rates for ovarian cancer precision medicine: Combination therapy targeting Snail and PARP1 in ovarian cancer subtypes, Role: PD/PI, Mary Kay Foundation, (07/2018 - 06/2020) Status: Closed
  • Anti-SNAIL1/PARP1 in Ovarian Cancer with BRCA1/2 Mutations, Role: Faculty Mentor, American Medical Association, (03/2017 - 03/2018) Status: Closed

State

  • Targeting cancer stem cells to prevent recurrence and metastasis of ovarian cancer, Role: PD/PI, California Institute for Regenerative Medicine, (03/2018 - 02/2020) Status: Closed